Back
Day Range
$52.53
$54.24
52-Week Range
$22.28
$59.55
Volume
4,423,528
50D / 200D Avg
$47.06
/
$32.47
Prev Close
$51.34
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.5 | 0.3 |
| P/B | 2.4 | 3.0 |
| ROE % | -28.9 | 3.7 |
| Net Margin % | -145.2 | 3.8 |
| Rev Growth 5Y % | -42.5 | 10.0 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$35.67
-33.4%
Low: $17.00
High: $63.00
Forward EPS
-$6.39
Est. Revenue
2.08B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.66
$1.98 – $4.35
|
6.67B | 6 |
| FY2029 |
-$0.03
-$0.05 – -$0.02
|
5.03B | 10 |
| FY2028 |
-$2.90
-$6.17 – $0.69
|
3.16B | 15 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | -$2.54 | -$2.11 | +17.1% |
| 2025-11-06 | -$1.87 | -$0.51 | +72.7% |
| 2025-08-01 | -$2.99 | -$2.13 | +28.8% |
| 2025-05-01 | -$2.92 | -$2.52 | +13.7% |
| 2025-02-14 | -$2.68 | -$2.50 | +6.7% |
| 2024-11-07 | -$1.91 | $0.03 | +101.6% |
| 2024-08-01 | -$3.35 | -$3.33 | +0.6% |
| 2024-05-02 | -$3.56 | -$3.07 | +13.8% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue declined -42.46% annually over 5 years
Debt/Equity of 0.22 — conservative balance sheet
Negative free cash flow of -2.07B
PEG of 0.19 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.23%
Capital efficient — spends only 9.88% of revenue on capex
Growth
Revenue Growth (5Y)
-42.46%
Revenue (1Y)-39.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-28.87%
ROIC-21.82%
Net Margin-145.16%
Op. Margin-158.13%
Safety
Debt / Equity
0.22
Current Ratio3.29
Interest Coverage0.00
Valuation
P/E Ratio
-7.49
Forward P/EN/A
P/B Ratio2.44
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -39.23% | Revenue Growth (3Y) | -46.72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -42.46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.94B | Net Income (TTM) | -2.82B |
| ROE | -28.87% | ROA | -22.87% |
| Gross Margin | 55.35% | Operating Margin | -158.13% |
| Net Margin | -145.16% | Free Cash Flow (TTM) | -2.07B |
| ROIC | -21.82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.22 | Current Ratio | 3.29 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.49 | Forward P/E | N/A |
| P/B Ratio | 2.44 | P/S Ratio | 10.88 |
| PEG Ratio | 0.19 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 10.18 | Fwd Earnings Yield | N/A |
| FCF Yield | -9.77% | ||
| Market Cap | 21.15B | Enterprise Value | 20.47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.94B | 3.20B | 6.85B | 18.88B | 17.74B |
| Net Income | -2.82B | -3.56B | -4.71B | 8.36B | 12.20B |
| EPS (Diluted) | -7.26 | -9.27 | -12.34 | 20.10 | 28.29 |
| Gross Profit | 1.08B | 1.74B | 2.16B | 13.46B | 15.12B |
| Operating Income | -3.07B | -3.95B | -4.24B | 9.42B | 13.30B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.34B | 14.14B | 18.43B | 25.86B | 24.67B |
| Total Liabilities | 3.69B | 3.24B | 4.57B | 6.74B | 10.52B |
| Shareholders' Equity | 8.65B | 10.90B | 13.85B | 19.12B | 14.15B |
| Total Debt | 1.92B | 747.00M | 1.24B | 1.20B | 916.00M |
| Cash & Equivalents | 2.60B | 1.93B | 2.91B | 3.21B | 6.85B |
| Current Assets | 6.54B | 8.10B | 10.33B | 13.43B | 16.07B |
| Current Liabilities | 1.99B | 2.21B | 3.02B | 4.92B | 9.13B |